Aiforia® Lung Cancer PD-L1

About Aiforia Technologies

Aiforia Technologies' mission is to transform pathology through AI-driven, quantitative image analysis, addressing critical challenges of diagnostic variability and workload. The company has achieved significant traction with a portfolio of CE-IVD marked clinical AI applications for cancers like prostate, breast, and lung, alongside a robust research platform. Its strategy centers on a cloud-native SaaS model, fostering collaboration with leading academic and clinical institutions to validate and expand its AI model library, thereby solidifying its position at the intersection of AI and digital healthcare.

Therapeutic Areas